TORONTO, May 7, 2024
/CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U)
("DRI" or "the Trust") is pleased to announce results of voting at
its annual general meeting ("AGM") of unitholders held on
May 7, 2024. All of the nominees for
election as trustees of the Trust referred to in its management
information circular dated March 26,
2024 were elected to serve as trustees for the ensuing year,
and Deloitte LLP was reappointed as auditors of the Trust.
Election of Trustees
Voting results for the election of each trustee were as
follows:
|
Trustee
|
Votes "for" as a
percentage
of votes cast for or withheld
for the trustee
|
Votes "withheld" as
a
percentage of votes cast for
or withheld for the trustee
|
|
Gary Collins
|
98.69 %
|
1.31 %
|
|
Ali Hedayat
|
83.69 %
|
16.31 %
|
|
Behzad
Khosrowshahi
|
91.36 %
|
8.64 %
|
|
Kevin Layden
|
83.70 %
|
16.30 %
|
|
Paul
Mussenden
|
92.46 %
|
7.54 %
|
|
Poonam Puri
|
98.49 %
|
1.51 %
|
|
Sandra
Stuart
|
98.63 %
|
1.37 %
|
|
Tamara
Vrooman
|
98.74 %
|
1.26 %
|
Appointment of Auditors
Unitholders also voted in favour of reappointing Deloitte LLP as
auditors of the Trust and authorizing the board of trustees to fix
their remuneration (99.98% in favour).
About DRI Healthcare
Trust
DRI Healthcare Trust is managed by DRI Capital Inc. ("DRI
Healthcare"), the pioneer in global pharmaceutical royalty
monetization with a 35-year history of accelerating innovation by
providing capital to inventors, academic institutions and biopharma
companies. Since its founding in 1989, DRI Healthcare has deployed
more than US$3.0 billion, acquiring
more than 70 royalties on 45-plus drugs, including Eylea, Keytruda,
Orserdu, Spinraza, Stelara, Vonjo, Zejula and Zytiga. DRI
Healthcare Trust's units are listed and traded on the Toronto Stock
Exchange in Canadian dollars under the symbol "DHT.UN" and in US
dollars under the symbol "DHT.U". To learn more, visit
drihealthcare.com or follow us on LinkedIn.
SOURCE DRI Healthcare Trust